These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4961572)

  • 1. Preliminary report on a new anti-Parkinson drug, UCB 1549.
    Strang RR
    Acta Neurol Psychiatr Belg; 1966 Sep; 66(9):771-6. PubMed ID: 4961572
    [No Abstract]   [Full Text] [Related]  

  • 2. Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.
    Koh CV; Ananth JV; Ban TA; Lehmann HE
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):289-91. PubMed ID: 4931413
    [No Abstract]   [Full Text] [Related]  

  • 3. Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study.
    Pecknold JC; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(5):367-70. PubMed ID: 4998432
    [No Abstract]   [Full Text] [Related]  

  • 4. [L-dopa and parkinsonism. A preliminary report].
    Pakkenberg H
    Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628
    [No Abstract]   [Full Text] [Related]  

  • 5. Dexbenzetimide in neuroleptic-induced parkinsonism. A double-blind crossover study with a 16-week follow-up.
    De Smedt R; Rodrigus E; Debandt R; Brugmans J
    J Clin Pharmacol J New Drugs; 1970; 10(3):207-11. PubMed ID: 4910278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience in the use of a new drug, amedine, in Parkinsonism].
    Vaĭnshtok AB; Oleĭnik LI
    Sov Med; 1971 Jan; 34(1):40-2. PubMed ID: 5580239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of 2 new antiparkinson drugs (UCB 1549 and SD 25)].
    Strang RR
    Nord Med; 1966 Oct; 76(43):1245-7. PubMed ID: 5918116
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of biperiden in Parkinson's disease.
    Strang RR
    Dis Nerv Syst; 1967 Mar; 28(3):191-3. PubMed ID: 5335879
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind clinical evaluation of UCB 1549 in treatment of Parkinson's disease.
    Strang RR
    Br Med J; 1966 Nov; 2(5522):1112-3. PubMed ID: 5331761
    [No Abstract]   [Full Text] [Related]  

  • 10. Mefexamide as an antiparkinson drug. (A double-blind study).
    Denber HC; Mohr CP
    Dis Nerv Syst; 1969 Apr; 30(4):250-3. PubMed ID: 4890010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F; Grünberger J; Oberhummer I
    Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease.
    Strang RR
    Curr Med Drugs; 1966 Dec; 7(4):20-6. PubMed ID: 5976205
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of disturbances of extrapyramidal system with methixene hydrochloride].
    Kuromaru S; Funasaka K; Shuta K
    No To Shinkei; 1969 Nov; 21(11):1301-9. PubMed ID: 5394922
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathochemical bases for the treatment of parkinsonism].
    Petelin LS; Tret'iakova KA; Pigarev VA; Romenskaia LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971 Dec; 71(12):1765-70. PubMed ID: 5143959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Parkinsonism with Tremarial (SJ-1977)].
    Kondo K; Takahashi Y; Yamamoto T; Matsumura K; Okuda Y
    No To Shinkei; 1967 Jul; 19(7):723-7. PubMed ID: 4384268
    [No Abstract]   [Full Text] [Related]  

  • 18. [Parlodel: a new therapeutic possibility in the management of Parkinson disease].
    Glaub T; Berecz G; Pintér N; Diószeghy P; Virga A; Mechler F
    Orv Hetil; 1988 Feb; 129(8):399-402. PubMed ID: 3279375
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of parkinsonism].
    Oftedal SI
    Tidsskr Nor Laegeforen; 1969 Apr; 89(7):489-91. PubMed ID: 5794674
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bulgarian antiparkinson preparations with a new mechanism of action].
    Ganev G; Karamalakov L; Tsekova M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(12):1864-9. PubMed ID: 6000490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.